social anxiety disorder

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Medicine & Technology Mar 08, 2021

The 40-year-old antidepressant drug, Fluvoxamine is currently being tested as a potential treatment for COVID-19. It has been authorized by the FDA to be considered for those at high risk of suffering severe symptoms of COVID-19.

social anxiety disorder

Fluvoxamine Antidepressant Drug Being Tested for COVID-19 Treatment

Most Popular

Plato’s Long-Lost Grave Found Using AI To Decipher Herculaneum Scrolls; Greek Philosopher Had Been Sold Into Slavery: Report

What’s Inside the Moon? Lunar Seismic Data Reveals Earth-Like Core

Influenza Shows Highest 'Pandemic Potential' Among Ranked Pathogens, Study Reveals

UFOs Piloted by Spiritual Entities? Fox News' Tucker Carlson Makes Bizarre Claim, Suggests That They Do Not Behave According to Laws of Science

NASA’s Juno Discovers Glass-Smooth Lake of Cooling Lava on Surface of Jupiter’s Moon Io

Recommended Stories

NASA Releases Stunning Concept Art of Lake Lava Loki Patera on Jupiter's Io Moon

Japan’s Moon Lander Woke Up for a Third Time After Surviving Another Frigid Two-Week Lunar Night

Russia Blocks US and Japan’s UN Resolution Preventing Dangerous Nuclear Arms Race in Space

Earth’s Quasi-Moon Kamo’oalewa Could Originate From Lunar Surface Not Asteroid Belt [Study]